AGX51

目录号: PL08515 纯度: ≥99%
AGX51 是首创的 pan-Id (inhibitors of DNA-binding/differentiation proteins) 拮抗剂和降解剂。AGX51 抑制 Id1-E47 相互作用,导致泛素介导的 Ids 降解,细胞生长停滞和活力降低。AGX51 能抑制 TNBC,其 IC50 值约为 25 nM。AGX51 可用于癌症的研究。
CAS No. :330834-54-3
商品编号 规格 价格 会员价 是否有货 数量
PL08515-5mg 5mg ¥2315.00 请登录
PL08515-10mg 10mg ¥3325.00 请登录
PL08515-25mg 25mg ¥5325.00 请登录
PL08515-50mg 50mg ¥7275.00 请登录
PL08515-100mg 100mg ¥9825.00 请登录
PL08515-200mg 200mg ¥13195.00 请登录
PL08515-500mg 500mg 询价 询价
PL08515-1 mL x 10 mM (in DMSO) 1 mL x 10 mM (in DMSO) ¥2545.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
AGX51
英文名称
AGX51
英文别名
AGX51;Oprea1_197579;STK082497;N-[3-(1,3-benzodioxol-5-yl)-3-(2-methoxyphenyl)propyl]-N-benzylpropanamide;N-[3-Benzo[1,3]dioxol-5-yl-3-(2-methoxy-phenyl)-propyl]-N-benzyl-propionamide;N-(3-(Benzo[d][1,3]dioxol-5-yl)-3-(2-methoxyphenyl)propyl)-N-benzylpropionamide
Cas No.
330834-54-3
分子式
C27H29NO4
分子量
431.52
包装储存
Pure form -20°C 3 years;4°C 2 years
详情描述

AGX51 是首创的 pan-Id (inhibitors of DNA-binding/differentiation proteins) 拮抗剂和降解剂。AGX51 抑制 Id1-E47 相互作用,导致泛素介导的 Ids 降解,细胞生长停滞和活力降低。AGX51 能抑制 TNBC,其 IC50 值约为 25 nM。AGX51 可用于癌症的研究。

产品详情
AGX51 是首创的 pan-Id (inhibitors of DNA-binding/differentiation proteins) 拮抗剂和降解剂。AGX51 抑制 Id1-E47 相互作用,导致泛素介导的 Ids 降解,细胞生长停滞和活力降低。AGX51 能抑制 TNBC,其 IC50 值约为 25 nM。AGX51 可用于癌症的研究。
生物活性
AGX51 is a first-in-class pan-Id (inhibitors of DNA-binding/differentiation proteins) antagonist and degrader. AGX51 inhibits the Id1-E47 interaction, leading to ubiquitin-mediated degradation of Ids, cell growth arrest, and reduces viability. AGX51 inhibits the TNBC cell lines with IC 50 s of nearly 25 μM. AGX51 can be used for the research of cancer.
性状
Oil
IC50 & Target[1][2]
IC50: 26.66 μM (4T1), 8.7 μM (HMLE RAS Twist), 22.28 μM (MDA-MB-157), 30.91 μM (MDA-MB-436), 36.55 μM (SK-BR-3), 60 μM (MCF-7), 10.89 μM (PDX-BR7), 11.97 μM (PDX-IBT) , 18.56 μM (PDX-BR11)
体外研究(In Vitro)
AGX51 (0-80 μM; 24 h) decreases ID1 protein levels in 4T1 cells.
AGX51 (40 μM; 0-72 h) decreases ID1 levels protein with a 40 μM concentratio in 4T1 cells.
AGX51 (40 μM; 24 h) influences 4T1 cells , ER+, HER2+, TNBC and three breast cancer PDX cell ines.
AGX51 (0-80 μM; 24-48 h) influences cell cycle of 4T1 cells.
AGX51 (40 μM; 4-24 h) influences phospho-histone H3 levels in 4T1 cells.
AGX51 (40 μM; 24 h) influences ROS levels in 4T1 cells. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
AGX51 (50 mg/kg; i.p. twice a day for 4 weeks) inhibits lung metastasis.
AGX51 (15 mg/kg; i.p. twice a day for 3 weeks) exibits anti-tumor activity with autochronous cancer. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Pure form -20°C 3 years;4°C 2 years
参考文献
[1]. Wojnarowicz PM, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021 May 24;7(1):58.
溶解度数据
In Vitro: DMSO : 100 mg/mL (231.74 mM; Need ultrasonic)Ethanol : 100 mg/mL (231.74 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Wojnarowicz PM, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021 May 24;7(1):58.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2